> About Arrow > Press Release

  For Immediate Release
Date: March 31, 2006
 
  Media contact:
Karla McGowan
VIA for Arrow International
207.221.3000 x1230
kmcgowan@vianow.com
Contact: Frederick J. Hirt, CFO
Phone: 610-478-3117

Arrow SmartSeal™ Sheath: Unique Valve Design for Use with Chronic Hemodialysis Catheters

Reading , PA , March 31, 2006—Air embolism is a serious concern with the insertion of dialysis catheters. Although perceived as infrequent, the effects are potentially fatal. Physicians need a simple, safe way to manage this risk. Arrow International’s response: the Arrow SmartSeal Hemostatic Peelable Dialysis Sheath, available in the United States both individually and in select chronic hemodialysis catheter kits.

The “brain” of the SmartSeal sheath is a unique dual hemostatic valve that plays three critical roles, says Arrow’s Jim Fitzpatrick, Vice President of Special Procedures Business Unit. “It’s designed to minimize risk of air embolism, minimize blood loss and reduce clinicians’ exposure to blood-borne pathogens during the entire catheterization procedure.”

SmartSeal is also engineered to ease insertion, with user-friendly features including:

  • Easy-to-grip tabs
  • Easy-to-peel sheath with break-away hemostatic valve
  • A sheath tip that enables smooth, atraumatic transition during insertion

“The SmartSeal sheath exemplifies Arrow’s commitment to safety and protection for patients and healthcare workers,” Fitzpatrick says.

Arrow International’s suite of catheter-based dialysis devices includes the Arrow Cannon ® II Plus Retrograde-Tunneled, Tip-First Chronic Hemodialysis Catheter, the Arrow Edge™ Antegrade-Tunneled Chronic Hemodialysis Catheter, the Arrow Simplicity™ Color-Coded Micro-Puncture Introducer Set and the Arrow-Trerotola™ PTD ®. Each is created in close consultation with the experts who use them, then designed with the unique features these experts need to treat their patients successfully. The resulting dialysis devices are as easy to use as they are effective.

Company Information

Arrow International, Inc. develops, manufactures and markets a broad range of clinically advanced, disposable catheters and related products for critical and cardiac care. The Company’s products are used primarily by anesthesiologists, critical care specialists, surgeons, emergency and trauma physicians, cardiologists, interventional radiologists, electrophysiologists, and other healthcare providers.

Arrow International’s news releases and other company information can be found on the on its website at http://www.arrowintl.com.

The Company’s common stock trades on The Nasdaq Stock Market® under the symbol ARRO.